Rabies is notoriously difficult to treat once symptoms begin, and that challenge starts at the molecular level. Unlike many ...

Hepatitis D or HDV, which only affects individuals infected with hepatitis B, is associated with a two- to six-fold higher ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

Improved understanding of how bacterial defense mechanisms operate may help scientists select phages with the best chance of ...

Assembly Biosciences, Inc. (NASDAQ: ASMB) is one of the growth stocks that could double by 2027. On June 25, the company ...

Got junk? Learn how a new study suggests that, when it comes to our genetic code, that may actually be a good thing.

Although outbreaks of Ebola virus are rare, the disease is severe and often fatal, with few treatment options. Rather than ...

Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment ...

Chronic hepatitis B treatment relies on nucleoside or nucleotide analogue drugs that suppress hepatitis B virus (HBV) ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and ...

A new study provides a detailed structure of a human enzyme critical for antiviral defense and platelet function.